GlassScriptPhysician profile
Ashley Clarissa Logan
NPI 1912446733
$2,482.69
in general payments reported to CMS, 2019-2025
32 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.85 · 2023: $357 · 2024: $872 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $246.43 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $203.12 | 2023-2025 | |
| Glaxosmithkline, LLC. | $200.44 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $190.53 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $189.65 | 2023-2025 | |
| Edwards Lifesciences Corporation | $172.31 | 2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $124.48 | 2022-2025 | Repatha, Otezla, Repatha |
| Exact Sciences Corporation | $119.25 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $117.38 | 2024-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $81.73 | 2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.35 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $73.32 | 2023-2025 | Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $63.42 | 2023-2025 | |
| Axsome Therapeutics, INC. | $62.35 | 2025 | Auvelity |
| Dexcom, INC. | $57.51 | 2024-2025 | Dexcom G6 Transmitter |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $56.93 | 2023-2025 | Spravato |
| Medtronic, INC. | $43.75 | 2023-2024 | Intellis Adaptivestim |
| Abbott Laboratories | $42.97 | 2023 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $41.04 | 2023-2024 | Heplisav-B |
| Boston Scientific Corporation | $40.87 | 2023-2024 | |
| Inspire Medical Systems, INC. | $36.08 | 2024 | Inspire |
| Surmodics, INC. | $34.73 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Abiomed | $33.03 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $26.13 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $25.33 | 2025 | Neffy |
| W. L. Gore & Associates, INC. | $24.66 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.15 | 2025 | Xifaxan |
| Stryker Corporation | $16.50 | 2023 | Prevalon |
| Takeda Pharmaceuticals U.S.A., INC. | $15.08 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.44 | 2024 | Quviviq |
| Angiodynamics, INC. | $13.41 | 2022 | |
| Organon LLC | $13.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.